Epilepsy can be a complex disorder.

Getting Out in the World

Overcome the Stigma

As if epilepsy itself were not enough to deal with, there are also the social and psychological challenges that come with it. In some social situations, including school and the workplace, a lack of information and understanding can make for some awkward moments, which can affect how you feel about yourself.

Educate others when you can. For the most part, any remaining negative feeling surrounding epilepsy comes from lack of knowledge, confusion about what epilepsy is, and outdated ideas. The good news is epilepsy is going the way of many other conditions that had biases attached to them a generation or two ago.

Educating yourself about your condition is one key to managing it. Educating others—as gently as possible, where and when appropriate—can also help. Think of it as another way of taking control.

Navigate the Workplace

Do you notify your boss of your condition? Your immediate supervisor? Anyone? And what about privacy? For that matter, when is your medical condition ever anyone’s business?

No single answer fits every situation except for those where safety—your own and that of others—is concerned. If you’re unsure about whether your condition or your treatment regimen will interfere with your being able to meet job requirements, ask your healthcare professional’s advice. Where safety is an issue, disclosure is a must.

Turn your colleagues into allies. If you choose to tell a supervisor, a co-worker, or a human resources representative about your condition, consider using the opportunity to educate her or him with a fact sheet describing how to give first aid in case of seizures. Having some idea of what a seizure is and how to treat it may make the person more comfortable with the situation—and make your life easier.

Know your rights. The Americans with Disabilities Act forbids prospective employers from asking if you have a disability during a job interview. You may decide to offer such information only on a "need-to-know" basis—unless it has a direct bearing on the job.

After a job offer has been made, an employer can ask questions about your medical history—especially where relevant to the position’s core requirements.

Ask your employer to make adjustments if you need them. If you find you need accommodation from your employer because of your condition, you may want to look into your legal rights before you ask. "Reasonable accommodation" may range from scheduling flexible hours to bringing a seizure-detection guide dog with you to work.

Report harassment. Employees with epilepsy sometimes face discrimination in the workplace. If you encounter harassment or discrimination, report it immediately, in writing; if it persists, look at your legal options without delay.

Deal With School and Your Peers

Don’t expect the worst from your peers. Young people with epilepsy deserve respect. And that may be, in fact, just what you get.

Your peers can be a great source of support and, given the opportunity, can help you stay involved with school, sports, activities, friendships, and all the other important things in your life. You may see a few negative reactions at first, or feel excluded, but most people usually come around.

Some may tell jokes as a way of covering their own embarrassment and uneasiness. (That’s an explanation, not an excuse. If you feel someone is out of line, tell the person—and tell her or him why.)

Epilepsy doesn’t rule your life—you do. As life goes on, having epilepsy doesn’t let you off the hook for all the other challenges involved in growing up. It also shouldn’t keep you away from the fun or from getting the education you need.

If you’re having problems concentrating in school because of your condition or your treatment, let your teachers know. If the problems are minor, your teachers can probably help you work around them once they understand what you need and why. If you’re really struggling, look into whether an Individual Education Plan (IEP) may be right for you.

Know why to stay away from street drugs. Everyone tells young people to avoid using street drugs; this is especially important for young people with epilepsy. Not only are street drugs dangerous in their own right, but, because they can interact with antiseizure medications in unpredictable ways, they can cause harm or interfere with your treatment.

Stay in touch with people who know. As always, your peers who have been through what you’re going through have a lot to say. The Epilepsy Foundation has a community Web site for young people.

Make Driving With Epilepsy Safer

Know the rules of the road. Safety—your own and that of others—is your most important consideration. If you’re confident that your condition will not affect your driving, and you can meet the legal requirements in your state, you may be ready to get behind the wheel. If you’re not sure about how well your treatment is working, or have any doubts about the effects of your treatment or whether your seizures are likely to recur, ask your physician.

If it’s legal for you to drive, and you’d like to drive, but you’re not entirely comfortable being on the road—take your time. Try driving with a friend, family member, or co-worker who understands your condition and can take the wheel if you feel uneasy.

State laws vary, but most insist on a seizure-free period of a certain length, a healthcare professional’s evaluation, or medical reports, often in some combination. Differing conditions are treated differently in some states. You can learn about your state’s driving laws and their impact on you at the Epilepsy Foundation’s Web site.


Access2wellness™ provides access to more than 1,000 free and discounted prescription medications for uninsured and underinsured individuals who qualify.

About TOPAMAX®

TOPAMAX® is approved as initial monotherapy in patients 2 years of age and older with partial-onset or primary generalized tonic-clonic seizures.

Safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials.

TOPAMAX® is approved as add-on therapy for patients 2 years of age and older with primary generalized tonic-clonic seizures, partial-onset seizures, or seizures associated with Lennox-Gastaut syndrome.

Important Safety Information

Warnings and Precautions

TOPAMAX ® may cause eye problems. Serious eye problems include: sudden decrease in vision with or without eye pain and redness; blockage of fluid in the eye causing increased pressure in the eye (secondary angle closure glaucoma). These eye problems can lead to permanent loss of vision if not treated. You should call your healthcare professional right away if you have any new eye symptoms.

TOPAMAX ® may cause decreased sweating and increased body temperature (fever). People, especially children, should be watched for signs of decreased sweating and fever, especially in hot temperatures. Some people may need to be hospitalized for this condition.

TOPAMAX ® can increase the level of acid in your blood (metabolic acidosis). If left untreated, metabolic acidosis can cause brittle or soft bones (osteoporosis, osteomalacia, osteopenia), kidney stones, can slow the rate of growth in children, and may possibly harm your baby if you are pregnant. Metabolic acidosis can happen with or without symptoms. Sometimes people with metabolic acidosis will: feel tired, not feel hungry (loss of appetite), feel changes in heartbeat, or have trouble thinking clearly. Your healthcare provider should do a blood test to measure the level of acid in your blood before and during your treatment with TOPAMAX ®. If you are pregnant, you should talk to your healthcare provider about whether you have metabolic acidosis.

Like other antiepileptic drugs, TOPAMAX ® may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Pay attention to any changes and call your doctor right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying, attempts to commit suicide, new or worse depression, new or worse anxiety, feeling agitated or restless, panic attacks, trouble sleeping (insomnia), new or worse irritability, acting aggressive, being angry or violent, acting on dangerous impulses, an extreme increase in activity and talking (mania), or other unusual changes in behavior or mood.

TOPAMAX ® may affect how you think, and cause confusion, problems with concentration, attention, memory, or speech, depression or mood problems, tiredness, and sleepiness.
Do not stop taking TOPAMAX ® without first talking to your doctor. Stopping TOPAMAX ® suddenly can cause serious problems.

If you take TOPAMAX ® during pregnancy, your baby has a higher risk for birth defects called cleft lip and cleft palate. These defects can begin early in pregnancy, even before you know you are pregnant. There may be other medicines to treat your condition that have a lower chance of birth defects. All women of childbearing age should talk to their healthcare providers about using other possible treatments instead of TOPAMAX ®. If the decision is made to use TOPAMAX ®, you should use effective birth control (contraception) unless you are planning to become pregnant. Tell your healthcare provider right away if you become pregnant while taking TOPAMAX ®. You and your healthcare provider should decide if you will continue to take TOPAMAX ® while you are pregnant. Metabolic acidosis may have harmful effects on your baby. Talk to your healthcare provider if TOPAMAX ® has caused metabolic acidosis during your pregnancy. If you become pregnant while taking TOPAMAX ®, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. You can enroll in this registry by calling 1-888-233-2334. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy.

TOPAMAX ® may cause high blood ammonia levels. High ammonia in the blood can affect your mental activities, slow your alertness, make you feel tired, or cause vomiting.

Taking TOPAMAX ® when you are also taking valproic acid can cause a drop in body temperature (hypothermia) to less than 95ºF, feeling tired, confusion, or coma.

Adverse Reactions

As monotherapy, the most common side effects of TOPAMAX ® (in the 400 mg/day group and at a higher rate, ≥ 5%, than the 50 mg/day group) in adults were tingling in arms and legs, weight decrease, loss of appetite, sleepiness, and difficulty with memory; and in children, fever, weight decrease, mood problems, cognitive problems, infection, flushing, and tingling in arms and legs.

In combination with other antiepileptic drugs (AEDs), the most common side effects of TOPAMAX ® in adults (200 to 400 mg/day) were sleepiness, dizziness, loss of muscle coordination, speech disorders and related problems, psychomotor slowing, abnormal vision, difficulty with memory, tingling in arms and legs, and double vision; and in children (5 to 9 mg/kg/day), fatigue, sleepiness, loss of appetite, nervousness, difficulty with concentration/attention, difficulty with memory, aggressive reaction, and weight decrease.

Tell your doctor about other medications that you are taking. Report any side effect that bothers you or that does not go away.

These are not all the possible side effects of TOPAMAX ®. For more information, ask your healthcare professional or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full US Prescribing Information and Medication Guide.

© Janssen Pharmaceuticals, Inc. 1999-2011. All rights reserved.

Your use of the information on this site is subject to the terms of our Legal Statement. Please see our Privacy Policy.

This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its contents.

Capitalized product names are trademarks of Janssen Pharmaceuticals, Inc.

This information is intended for use by our customers, patients and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc. recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.

This site was last modified on: Dec 28 2010 at 03:16:39 EST